NTAGI group to review SII's Covovax data for use in 12 yrs and above 0 30.03.2022 14:07 Business Standard A Covid working group of NTAGI will review this week data of SII anti-coronavirus jab Covovax to decide whether it can be included vaccination programme for inoculating those aged 12 years and above Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
